References
Firsov AA, Chernykh VM, Navashin SM: Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model. Antimicrob Agents Chemother 1990, 34:1312–1317.
Firsov AA, Lubenko IY, Vostrov SN, et al.: Antistaphylococcal effect related to the area under the curve/MIC ratio in an in vitro dynamic model: predicted breakpoints versus clinically achievable values for seven fluoroquinolones. Antimicrob Agents Chemother 2005, 49:2642–2647.
Forrest A, Chodosh S, Amantea MA, et al.: Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother 1997, 40(Suppl A):45–57.
Preston SL, Drusano GL, Berman AL, et al.: Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection. Antimicrob Agents Chemother 1998, 42:1098–1104.
Firsov AA, Vostrov SN, Lubenko IY, et al.: In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus. Antimicrob Agents Chemother 2003, 47:1604–1613.
Zhao X, Drlica K: Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis 2001, 33:147–156.
Zinner SH, Lubenko IY, Gilbert D, et al.: Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing. J Antimicrob Chemother 2003, 52:616–622.
Firsov AA, Smirnova MV, Lubenko IY, et al.: Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model. J Antimicrob Chemother 2006, 58:1185–1192.
Tam VH, Louie A, Deziel MR, et al.: Bacterial-population responses to drug-selective pressure: examination of garenoxacin’s effect on Pseudomonas aeruginosa. J Infect Dis 2005, 192:420–428.
Campion JJ, McNamara PJ, Evans ME: Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments. Antimicrob Agents Chemother 2004, 48:4733–4744.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zinner, S.H., Firsov, A. Antibiotic pharmacodynamics and bacterial resistance: Usefulness of in vitro models. Curr Infect Dis Rep 9, 175–177 (2007). https://doi.org/10.1007/s11908-007-0027-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-007-0027-y